Homocysteine and post-angioplasty restenosis

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 13, Issue 6, 2003, Pages 391-397

  Ambrosi, P ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Coronary angioplasty; Folic acid; Homocysteine; Restenosis

Indexed keywords

BIOLOGICAL MARKER; FOLIC ACID; HOMOCYSTEINE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; HYPERHOMOCYSTEINEMIA; INTIMA; NONHUMAN; PATHOGENESIS; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; RESTENOSIS; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 2342486081     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(03)80009-1     Document Type: Review

References (50)

1. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354: 407-413
2. Ueland PM, Refsum H, Beresford SA, Vollset SE (2000) The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 72: 324-332
3. Brattstrom L, Wilcken DE (2000) Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72: 315-323
4. Thambyrajah J, Townend JN (2000) Homocysteine and atherothrombosis - mechanisms for injury. Eur Heart J 21: 967-974
5. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126
6. Casscells W (1992) Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86: 723-729
7. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111-128
8. Ambrosi P, Garçon D, Riberi A, Habib G, Barlatier A, Kreitmann B, Rolland PH, Bouvenot G, Luccioni R, Métras D (1998) Association of mild hyperhomocysteinemia with cardiac graft vascular disease. Atherosclerosis 138: 347-350
9. Caldera A, Dec GW (2002) Hyperhomocysteinemia and transplant coronary artery disease. Transplantation 74: 1359-1364
10. Weis M, Von Scheidt W (1997) Cardiac allograft vasculopathy. Circulation 96: 2069-2077
11. Hansrani M, Gillepsie JI, Stansby G (2002) Homocysteine in myointimal hyperplasia. Eur J Vasc Endovasc Surg 23: 3-10
12. Krasinski K, Spyridopoulos I, Asahara T, Van der Zee R, Isner JM, Losordo DW (1997) Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 95: 1772-1778
13. Dudman NP, Hicks C, Wang J, Wilcken DE (1991) Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 91: 77-83
14. Tsai JC, Perrella MA, Yoshimuzi M (1994) Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 91: 6369-6373
15. Wang H, Yoshizumi M, Lai K (1997) Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 272: 25380-25385
16. Brown JC, Rosenquist TH, Monoghan DT (1998) ERK2 activation by homocysteine in vascular smooth muscle cells. Biochem Biophys Res Commun 251: 669-676
17. Mujumdar VS, Hayden Mr, Tiagy SC (2000) Homocysteine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol 183: 23-36
18. Suzuki YJ, Lorenzi MV, Shi SS, Day RM, Blumberg JB (2000) Homocysteine exerts cell type specific inhibition of AP-1 transcription factor. Free Radic Biol Med 28: 39-45
19. Vadiveloo PK, Filonzi EK, Stanton HR, Hamilton JA (1997) G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. Atherosclerosis 133: 61-69
20. Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58: 731-741
21. Matthias D, Becker CH, Riezler R, Kindling PH (1996) Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis 122: 201-216
22. Lubec B, Labudova O, Hoeger H (1996) Homocysteine increases cyclin-dependent kinase in aortic rat tissue. Circulation 94: 2620-2625
23. Rolland PH, Friggi A, Barlatier A, Piquet P, Latrille V, Faye MM, Guillou J, Charpiot P, Bodard H, Ghiringhelli O, Luccioni R (1995) Hyperhomocysteinemia-induced vascular damage in the minipig. Circulation 91: 1161-1174
24. Ambrosi P, Rolland PH, Bodard H, Charpiot P, Guisguand G, Ghiringhelli O, Habib G, Bouvenot G, Garçon D, Luccioni R (1999) Effect of folate supplementation in hyperhomocysteinemic pigs. J Am Coll Cardiol 34: 274-279
25. Chen C, Surowiec SM, Morsy AH, Ma M (2002) Intraperitoneal infusion of homocysteine increases intimal hyperplasia in balloon-injured rat carotid arteries. Atherosclerosis 160: 103-114
26. Morita H, Kurihara H, Yoshida S, Saito T, Shindo T, Oh-hashi Y, Kurihara Y, Yazaki T, Nagai R (2001) Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation 103: 133-139
27. Southern F, Eidt J, Drouilhet J, Mukunyadzi P, Williams DK, Cruz C, Wang Y, Poirier LA, Brown AT, Moursi MM (2001) Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasia. Atherosclerosis 15: 129-138
28. Cook JW, Malinow MR, Moneta GL, Taylor LM, Orloff SL (2002) Neointimal hyperplasia in balloon-injured rat carotid artery; the influence of hyperhomocysteinemia. J Vasc Surg 35: 158-165
29. Smith TP, Cruz CP, Brown AT, Eidt JF, Moursi MM (2001) Folate supplementation inhibits intimal hyperplasia induced by a high-homocysteine diet in a rat carotid endarterectomy model. J Vasc Surg 34: 475-481
30. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30: 1428-1436
31. Hausleiter J, Kastrati A, Mehilli J, Schuhlen H, Pache J, Dotzer F, Dirschinger J, Schomig A (2002) Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol 40: 882-889
32. Schneede J, Refsum H, Ueland PM (2000) Biological and environmental determinants of plasma homocysteine. Semin Thromb Haemost 26: 263-279
33. Kang SS, Wong PW (1996) Genetic and non genetic factors for moderate hyperhomocysteinemia. Atherosclerosis 119: 135-138
34. Kosokabe T, Okumura K, Sone T, Kondo J, Tsuboi H, Mukama H, Tomida T, Suzuki T, Hamiya H, Matsui H, Hayakawa T (2001) Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting. Circulation 103: 2048-2054
35. Van Bockxmeer FM, Mamotte CDS, Vasikaran SD, Raylor RR (1997) Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 95: 21-23
36. Tsakiris DA, Tschopl M, Jager K (1999) Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 142: 193-200
37. Benoit C, Furber A, Le Bouil A, Merheb M, Tadei A, Allain P, Geslin P (1999) Plasma homocysteine is not a predictive factor of restenosis after coronary angioplasty. Arch Mal Coeur Vaiss 92: 1457-1460
38. Morita H, Kurihara H, Kuwaki T, Hamada C, Kitaoka M, Suzuki S, Yazaki Y, Nagai R (2000) Homocysteine as a risk factor for restenosis after coronary angioplasty. Thromb Haemost 84: 27-31
39. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM (2002) Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. Eur Heart J 23: 726-733
40. Kumbasar SD, Dincer I, Ertas F, Gulec S, Erol C, Akyurek O, Kilickap M, Oral D, Sipahi E, Laleli Y (2001) Hyperhomocysteinemia and restenosis. J Cardiovasc Risk 8: 9-13
41. Marcucci R, Prisco D, Brunelli T, Pepe G, Gori AM, Fedi S, Capanni M, Simonetti I, Federici G, Pastore A, Abbate R, Gensini GF (2000) Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty. Thromb Haemost 83: 826-832
42. Miner SE, Hegele RA, Sparkes J, Teitel JM, Bowman KA, Connelly PW, Banijamali H, Lau HK, Chisholm RJ, Babaei S, Strauss BH (2000) Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study. Am Heart J 140: 272-278
43. Genser D, Prachar H, Hauer R, Halbmayer WM, Mlczoch J, Elmad I (2000) Relation of homocysteine, vitamin B(12) and folate to coronary in-stent restenosis. Am J Cardiol 89: 495-499
44. Zairis MN, Ambrose JA, Manousakis SJ, Stefanidis AS, Papadaki OA, Bilianou HI, DeVoe MC, Fakiolas CN, Pissimissis EG, Olympios CD, Foussas SG, For the GENERATION study group (2002) The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting. J Am Coll Cardiol 40: 1375-1382
45. Dudman PB (1999) An alternative view of homocysteine. Lancet 354: 2072-2074
46. de Lorgeril M, Salen P, Paillard F, Lacan P, Richard G (1999) Lipid-lowering drugs and homocysteine. Lancet 353: 209-210
47. Homocysteine Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316: 894-898
48. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345: 1593-1600
49. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12 and vitamin B6 on clinical outcome after percutaneous coronary intervention. JAMA 288: 973-979
50. Usui, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T (1999) Endothelial dysfunction by acute hyperhomocysteinemia: restoration by folic acid. Clin Sci 96: 235-239